COMMUNIQUÉ DE PRESSE publié le 15/11/2023 à 12:45, il y a 1 année 4 mois NanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications
COMMUNIQUÉ DE PRESSE publié le 14/11/2023 à 12:45, il y a 1 année 4 mois Broad-Spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Effective in an Animal Model for MPox and Smallpox Drug Development
COMMUNIQUÉ DE PRESSE publié le 16/10/2023 à 12:45, il y a 1 année 5 mois NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Active Against Coronaviruses as well as RSV
COMMUNIQUÉ DE PRESSE publié le 12/10/2023 à 12:45, il y a 1 année 5 mois NanoViricides, Inc. to Present at the Partnership Opportunities in Drug Delivery Conference in Boston on October 16, 2023 at 6:07pm ET
COMMUNIQUÉ DE PRESSE publié le 21/08/2023 à 12:45, il y a 1 année 7 mois The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricides
COMMUNIQUÉ DE PRESSE publié le 11/07/2023 à 12:45, il y a 1 année 9 mois Company’s Broad-Spectrum Antiviral NV-387 Has Demonstrated Excellent Effectiveness in RSV in a Lethal Lung Disease Animal Model, Reports NanoViricides
COMMUNIQUÉ DE PRESSE publié le 06/07/2023 à 12:45, il y a 1 année 9 mois Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs
COMMUNIQUÉ DE PRESSE publié le 29/06/2023 à 12:45, il y a 1 année 9 mois NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
COMMUNIQUÉ DE PRESSE publié le 31/05/2023 à 12:40, il y a 1 année 10 mois NanoViricides, Inc. to Present at the BIO International Convention in Boston on June 5th, 2023 at 3:15pm ET
COMMUNIQUÉ DE PRESSE publié le 16/05/2023 à 12:45, il y a 1 année 10 mois NanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Begin
Publié le 11/04/2025 à 13:49, il y a 1 heure 4 minutes Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 mars 2025
Publié le 11/04/2025 à 13:49, il y a 1 heure 4 minutes Statement about the number of shares composing the share capital and the number of voting rights as at March 31, 2025
Publié le 11/04/2025 à 13:36, il y a 1 heure 17 minutes Nombre total d'actions et droits de vote - mars 2025
Publié le 11/04/2025 à 13:36, il y a 1 heure 17 minutes Number of shares and voting rights - March 2025 (In French only)
Publié le 10/04/2025 à 18:04, il y a 20 heures 49 minutes Modalités de mise à disposition du Rapport sur la solvabilité et la situation financière 2024 du Groupe des Assurances du Crédit Mutuel
Publié le 11/04/2025 à 14:30, il y a 23 minutes Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement
Publié le 11/04/2025 à 14:00, il y a 53 minutes Greta Van Susteren Signs Multi-Year Renewal with Newsmax
Publié le 11/04/2025 à 14:00, il y a 53 minutes APPULSE CORPORATION (Listed on the TSX Venture Exchange - Symbol 'APL') Press Release - Reporting Results for the 2024 Fiscal Year
Publié le 11/04/2025 à 13:30, il y a 1 heure 23 minutes Gratomic Announces Anticipated Default in Filing Financial Statements and Application for Management Cease Trade Order
Publié le 11/04/2025 à 12:45, il y a 2 heures 8 minutes April 11thMako Mining Reports Fourth Quarter and Full Year 2024 Financial Results, Including 2024 Adjusted EBITDA(1) of US$42.2 million and EPS of US$0.27 from 39,001 oz Gold Sold at an Average Price of US$2,397/oz
Publié le 11/04/2025 à 13:24, il y a 1 heure 29 minutes Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Publié le 11/04/2025 à 13:06, il y a 1 heure 47 minutes Turkiye Garanti Bankasi A.S.: Approval of the election of the Independent Audit Company by the General Assembly
Publié le 11/04/2025 à 13:01, il y a 1 heure 52 minutes Turkiye Garanti Bankasi A.S.: Announcement regarding the registration of the Ordinary General Shareholders’ Meeting
